The purpose of this report is to describe the effect of body mass index (BMI) on 30-day and late outcome in patients having aortic valve replacement (AVR) for aortic stenosis (AS) with or without concomitant coronary artery bypass grafting. From January 2002 through June 2010 (8.5 years), 1,040 operatively excised stenotic aortic valves were submitted to the cardiovascular laboratory at Baylor University Medical Center at Dallas. Of the 1,040 cases 175 were eliminated because they had a previous cardiac operation. The present study included 865 adults whose AVR for AS was their first cardiac operation. Propensityadjusted analysis showed that 30-day and late mortality were strongly and significantly associated with BMI. Decreased risk of 30-day and long-term mortality was observed for patients with BMI in the low 30s compared to patients with BMI in the mid 20s or >40 kg/m 2 . In conclusion, the findings in this study indicate a strong and significant adjusted association between BMI and 30-day and long-term mortality in patients having AVR for AS with or without concomitant coronary artery bypass grafting. 
Methods
The surgical pathology files of the cardiovascular laboratory-a part of the pathology department at Baylor University Medical Center (BUMC) at Dallas-were searched for patients having operatively excised aortic valves without simultaneous repair or replacement of the mitral valve or evidence of mitral stenosis. From January 2002 through June 2010 (102 months or 8.5 years) 1,040 operatively excised stenotic aortic valves were submitted to the cardiovascular laboratory at BUMC. Of the 1,040 cases 175 were eliminated from the present study because they had had a previous cardiac operation and/or an operative procedure on the mitral valve. The present study includes 865 adults whose AVR for AS was their first cardiac operation with or without a first simultaneous coronary artery bypass grafting (CABG) procedure. Clinical, echocardiographic, hemodynamic, angiographic, and operative records were sought from patients' medical records and/or the BUMC Apollo cardiovascular database. Information on death of any patient was obtained from medical records for deaths during hospitalization at the time of AVR and from the Society of Thoracic Surgeons national database and/or from the Social Security Death Index for deaths after hospitalization. Echocardiographic data preoperatively were available to us in 426 patients and hemodynamic/angiographic data in 561 patients. These procedures also were performed in the other patients but at other institutions before their hospitalization at BUMC. The results of these studies at the referring institutions were not available to us. This study was approved by the institutional review board at BUMC and the requirement for individual patient consent was waived.
Means Ϯ SDs and percentages were calculated to describe the study cohort. Differences in demographic, clinical, and morphologic details were tested with a Wilcoxon (for continuous factors) or a chi-square (for categorical factors) test. A Bonferroni correction was employed to account for multiplicity.
To better describe our study cohort, the crude association of BMI and the other factors considered for this study is presented by categorizing BMI into the following categories: Յ25, 26 to 30, 31 to 40, and Ͼ40 kg/m 2 . To rigorously assess the adjusted association between BMI and short-/long-term mortality and avoid bias inference regarding BMI and mortality, we modeled BMI using restricted cubic splines in the statistical models used for this analysis. A propensity-score approach was used to assess the adjusted association between BMI and 30-day and long-term mortality. 3, 4 The propensity score was estimated using a linear regression model with BMI being the outcome and age, gender, race, aortic valve structure, valve weight, systemic hypertension, ascending aorta replaced, and type of implanted valve as possible confounding factors. Restricted cubic splines were used for all continuous variables.
1,2 Multiple imputation using predictive mean matching was used to account for missing data regarding the independent variables in this model. 4 Estimates from the aforementioned propensity model were then used to adjust the effect of concomitant BMI on 30-day mortality in a logistic regression model and on long-term mortality in a Cox proportional hazards model. Possible effect modification by gender and age was investigated for the 2 models and ruled out. The GrambschTherneau test statistic was used to test for proportionality of hazards in the Cox model. 
Results
The crude analysis showed that of the 14 factors analyzed, age, aortic valve area, 30-day mortality, and type substitute valve implanted were the only factors significantly different among the 4 BMI groups (Table 1) . Among the 3 age groups (21 to 50, 51 to 70, and 71 to 95 years) the oldest group had the highest percent with ideal (Յ25 kg/m 2 ) BMI, and the middle-age group had the highest percent with morbid obesity (BMI Ͼ40 kg/m 2 ). Overweight (BMI Ͼ25 kg/m 2 ) was present in 46 of the 64 patients (72%) age 21 to 50 years; in 256 of the 338 patients (76%) age 51 to 70 years, and in 275 of the 463 patients (59%) age 71 to 95 years (p Ͻ0.001). Aortic valve area was inversely related to . Propensity-adjusted (proportional hazard model) curves depicting probability of survival at 5 years by body mass index in patients who underwent aortic valve replacement for aortic stenosis. The propensityadjusted model includes the following risk factors: age, gender, race, body mass index, aortic valve structure, valve weight, history of systemic hypertension, ascending aorta replaced, and type of implanted valve (adjusted p ϭ 0.003).
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Valvular Heart Disease/BMI in AS BMI (p Ͻ0.001). Type of substitute valve inserted also varied with BMI: the greater the BMI, the greater the chance that a mechanical prosthesis was used; conversely, the lower the BMI, the greater the likelihood that a bioprosthesis was used (p ϭ 0.008). Of the 209 patients having a mechanical prosthesis, 152 (73%) were overweight (BMI Ͼ25 kg/m 2 ), and of the 649 patients having a bioprosthesis, 419 (65%) were overweight. Thirty-day and late mortality were strongly associated with the lowest and the highest BMI (Figures 1 through 4) .
Concomitant CABG, type of native aortic valve excised (unicuspid, bicuspid, or tricuspid), and weight of the operatively excised aortic valves were insignificantly different among the 4 BMI groups. Although days in the hospital after AVR ranged from 3 to 71 days, mean and median days in the hospital after AVR Ϯ CABG were not significantly different among the 4 BMI groups.
Propensity-adjusted analysis executed by modeling BMI using restricted cubic splines indicated a strong and significant association between BMI and 30-day (p ϭ 0.026; Figure 1 ) and long-term (9-year follow-up, p ϭ 0.003; Figures 2 through 4 ) mortality. [1] [2] [3] Decreased risk of 30-day and long-term mortality was observed for patients with BMI in the low 30s compared to patients with BMI in the mid 20s or Ͼ40 kg/m 2 .
Discussion
Many publications have appeared describing the effect of BMI on outcomes after cardiac surgery. 6 -23 Most have been limited to patients who had CABG only. 6,8 -11,13,14,18,22 Some have described the effect of BMI on outcomes after cardiac surgery but these reports make it impossible to tease out the effect of BMI on outcomes of isolated AVR with or without concomitant CABG. 7, 12, [15] [16] [17] 21 A few reports have appeared describing the effect of BMI on outcomes after AVR and those that have appeared have included AVR not only for AS but also for pure AR and infective endocarditis. 19 19 identified a low BMI (Ͻ24) as an independent risk factor for 30-day and 6-month mortality. Tjang et al 24 reviewed 28 studies on predictors of mortality after AVR and did not mention BMI in their otherwise scholarly report. Florath et al 23 reporting on AVR in octogenarians found BMI Ͻ24 to be a major risk factor for mortality after AVR.
The present study avoided the problems inherent with BMI categorization by modeling BMI using restricted cubic splines. [1] [2] [3] Our findings indicate a strong and significant adjusted association between BMI and 30-day and longterm mortality. Better 30-day and long-term survival was observed for patients with BMI in the low 30s compared to patients with BMI in the mid 20s or Ͼ40 kg/m 2 . A major strength of the present study is that BMI was modeled using restricted cubic splines to avoid grouping it into arbitrary categories and/or assuming linear (or other shaped) associations between BMI and the study outcomes. Figure 4 . Propensity-adjusted (proportional hazard model) curves depicting probability of survival at 7.5 years by body mass index in patients who underwent aortic valve replacement for aortic stenosis. The propensityadjusted model includes the following risk factors: age, gender, race, body mass index, aortic valve structure, valve weight, history of systemic hypertension, ascending aorta replaced, and type of implanted valve (adjusted p ϭ 0.003).
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